Filing Details
- Accession Number:
- 0000950138-19-000139
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-13 18:10:54
- Reporting Period:
- 2019-03-11
- Accepted Time:
- 2019-03-13 18:10:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1739104 | Elanco Animal Health Inc | ELAN | Pharmaceutical Preparations (2834) | 825497352 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1752446 | Alan David Urbanek | C/O Elanco Animal Health Incorporated 2500 Innovation Way Greenfield IN 46140 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-03-11 | 2,021 | $0.00 | 14,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- On March 11, 2019, Eli Lilly and Company ("Lilly") announced the completion of its offer to exchange shares of Lilly common stock for all of the common stock of the Issuer owned by Lilly (the "Exchange Offer"). The Reporting Person tendered 3,294 shares of Lilly common stock in the Exchange Offer, which shares were subject to a proration factor of 13.5970839%. As a result, the Reporting Person received 2,021 shares of Issuer common stock in exchange for 448 shares of Lilly common stock accepted in the Exchange Offer, based on an exchange ratio of 4.5121 shares of Issuer common stock for each share of Lilly common stock accepted.
Billionaire Hedge Funds
